An open-label, dose-ranging trial of AL 721 in patients with persistent generalized lymphadenopathy and AIDS-related complex

  • Donna Mildvan
  • , Jeffrey Buzas
  • , Donald Armstrong
  • , Diana Antoniskis
  • , Henry S. Sacks
  • , Frank S. Rhame
  • , Erwin W. Mosbach
  • , Carla Pettinelli

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'An open-label, dose-ranging trial of AL 721 in patients with persistent generalized lymphadenopathy and AIDS-related complex'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science